Wangzhi Li
Stock Analyst at Ladenburg Thalmann
(3.00)
# 1,079
Out of 4,667 analysts
5
Total ratings
75%
Success rate
40.79%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Wangzhi Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BGNE BeiGene | Upgrades: Buy | $278 | $194.56 | +42.89% | 2 | Dec 8, 2020 | |
| KRYS Krystal Biotech | Initiates: Buy | $23 | $182.29 | -87.38% | 1 | Oct 18, 2017 | |
| LPTX Leap Therapeutics | Initiates: Buy | $180 | $2.58 | +6,876.74% | 1 | Mar 7, 2017 | |
| CLRB Cellectar Biosciences | Initiates: Buy | $270 | $1.58 | +16,988.61% | 1 | Dec 21, 2016 |
BeiGene
Dec 8, 2020
Upgrades: Buy
Price Target: $278
Current: $194.56
Upside: +42.89%
Krystal Biotech
Oct 18, 2017
Initiates: Buy
Price Target: $23
Current: $182.29
Upside: -87.38%
Leap Therapeutics
Mar 7, 2017
Initiates: Buy
Price Target: $180
Current: $2.58
Upside: +6,876.74%
Cellectar Biosciences
Dec 21, 2016
Initiates: Buy
Price Target: $270
Current: $1.58
Upside: +16,988.61%